ALTIS
ALTIS is a Turkish contract research organization (CRO) founded in 2001 that provides Phase 1-4 clinical trials, regulatory affairs, data management, biostatistics, medical software, and personnel staffing services to pharmaceutical, biotechnology, and medical device companies across 17 cities in Turkey.
- Company typePrivate
- Founded2001
- HeadquartersKadikoy
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ALTIS does
ALTIS is a Turkish Contract Research Organization (CRO) founded in 2001 and headquartered in Istanbul's Şişli district. The company provides comprehensive clinical research services for the pharmaceutical, biotechnology, and medical device industries, operating across 17 Turkish cities with more than 130 personnel. It is officially approved by the Turkish Ministry of Health (General Directorate of Pharmaceuticals and Pharmacy) to operate under Good Clinical Practice Guidelines and is authorized to submit studies to the Turkish Medicines and Medical Devices Agency (TMMDA). The company is privately held as a Turkish Ltd. Şti. with no disclosed external institutional investors.
Its service portfolio spans the full clinical research lifecycle: Phase 1-4 clinical trials, observational studies, medical device studies, regulatory affairs support, medical software/document preparation (CRF/eCRF design, protocol writing), IXRS/IVRS/IWRS randomization systems, data management and biostatistics, qualified clinical research personnel staffing, and professional training through Altis Academy and the Altis E-School remote learning platform. A sister company, AlfaBeta CRO (established 2010), is Turkey's first biostatistics firm and provides integrated statistical analysis services. The company maintains a documented Quality Management System (board-approved 2017) and an Information Security Management System with annual review.
ALTIS generates revenue through professional services engagements on quote-based, project-specific pricing. The go-to-market motion is direct enterprise field sales, led by a Director of Business Development with 23 years of industry experience, targeting pharmaceutical companies, biotech firms, and medical device manufacturers requiring clinical trial execution in Turkey. Primary segments are domestic and international pharma, medical device manufacturers, biotech firms, and clinical research professionals seeking training. The company is founder-led: Dr. Emin Mehmet Yusuf (MD, MS Biomedical Engineering from Boğaziçi, PhD Biostatistics from Cerrahpaşa) as General Manager & Managing Partner with 30+ years of experience, and Derya Tekin Yusuf as Founding Partner.
ALTIS firmographics
Firmographics- Name
- ALTIS
- Legal name
- Altis Tıbbi Araştırma Organizasyon Eğitim ve Danışmanlık Ltd. Şti.
- Website
- https://altis.org
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ALTIS is a Turkish contract research organization (CRO) founded in 2001 that provides Phase 1-4 clinical trials, regulatory affairs, data management, biostatistics, medical software, and personnel staffing services to pharmaceutical, biotechnology, and medical device companies across 17 cities in Turkey.
- Ownership category
- akta.pro rank
ALTIS industry classification
Industry- Product category
- Contract Research Services (Clinical Research Organization)
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
Keywords
Where ALTIS is headquartered
LocationHeadquarters
- HQ city
- Kadikoy
Offices16 records
Markets served
ALTIS business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: ALTIS generates revenue by providing comprehensive clinical research services to pharmaceutical and biomedical companies. Services include Phase 1-4 clinical trials, observational studies, medical device studies, regulatory affairs support, data management and statistics, training, and clinical research personnel staffing.
- Qualified Clinical Research Personnel Supply: Supply of qualified clinical research personnel including Clinical Research Associates (CRAs), Project Managers, Site Managers, Regulatory Submission Specialists, Clinical Research Nurses, and Medical Translators to pharmaceutical and biotech companies conducting clinical trials.
- Training Services: ALTIS Academy provides clinical research training programs including CRA School, GCP training, investigator meetings, and statistics training. Training services are offered both for internal staff development and potentially as standalone services to external clients.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
ALTIS product offering
Product offeringCore offering
ALTIS is a Contract Research Organization (CRO) that provides comprehensive clinical research services to pharmaceutical, biotechnology and medical device companies operating in Turkey. Its offerings cover Phase 1–4 clinical trials, observational and medical device studies, regulatory submissions to the Turkish Medicines and Medical Devices Agency (TMMDA), data management and biostatistics, medical software (protocols, CRF/eCRF), Interactive Voice/Web Response Systems (IXRS/IVRS/IWRS), training through Altis Academy, and supply of qualified clinical research personnel.
Product overview
ALTIS is a Contract Research Organization (CRO) providing comprehensive clinical research services for the pharmaceutical and biomedical industries since 2001. The company operates as a unified service platform rather than a software product company, offering integrated clinical trial management, regulatory submissions, data management and statistics, medical software, training (via Altis Academy), and qualified personnel supply services. The core offerings include Clinical Trials (Phase 1-4), Support Services (data management, IWR systems, patient support), Medical Software (protocol writing, CRF/eCRF design), Regulatory Authority Submissions to TMMDA, and Therapeutic Areas expertise. The company also operates through its subsidiary AlfaBeta CRO (Turkey's first biostatistics firm) and provides training via Altis Academy and Altis E-School. Services span 17 cities across Turkey with over 130 personnel.
Differentiator
Problem solved
Functional benefit
Brands
- Altis Academy: Training and development platform for employees including Altis E-School for remote training
- Altis E-School
Products and services
- Clinical Trials Comprehensive clinical trial management services including feasibility assessments, site and investigator selection, monitoring, co-monitoring, site management, patient recruitment, and audit/compliance support for Phase 1–4 clinical trials, observational studies, early access programs, and medical device studies. Targeted at pharmaceutical, biotech, and medical device companies.
- Support Services Bundled support offerings including data management and statistics, training, patient support program, site support service, medical consulting, and Interactive Voice/Web Response (IWR) Systems for clinical trial drug allocation and data capture. Targeted at pharmaceutical and biomedical sponsors.
- Medical Software Document preparation services for clinical research including protocol writing, Case Report Form (CRF) and Electronic Case Report Form (eCRF) design, Informed Consent Form design, clinical study final reports, protocols and amendments, and synopses. Targeted at pharmaceutical and biotech sponsors running clinical trials.
- Regulatory Authority Submissions Submission support services to Ethics Committees and the Turkish Medicines and Medical Devices Agency (TMMDA) for pharmaceutical and non-pharmaceutical clinical trials, including amendment applications. Targeted at sponsors requiring Turkish regulatory authorization.
- Data Management and Statistics Statistical and data management services including database preparation, data entry, CRF/eCRF preparation, double data entry, validation, query management, Data Management Plan and Statistical Analysis Plan development, sample size calculation, randomization, and interim and final statistical analysis. Targeted at clinical trial sponsors.
- Therapeutic Areas Clinical research expertise across multiple therapeutic areas including endocrinology, infectious diseases, physical therapy and rehabilitation, gastroenterology, pulmonology, hematology, cardiology, nephrology, neurology, ophthalmology, oncology, pathology, and psychiatry. Targeted at pharmaceutical and biotech sponsors with indication-specific trials.
- Supply of Qualified Clinical Research Personnel Staffing solutions providing qualified clinical research personnel including Clinical Research Associates (CRA), Senior Clinical Research Specialists, Project Managers, Field Managers, Regulatory Submission Specialists, Clinical Research Nurses, and Medical Translators. Targeted at pharmaceutical and biotech companies conducting clinical trials.
- Altis Academy Training Programs Professional training services for clinical research including Good Clinical Practices (GCP), CRA School, investigator meetings, monitor and investigator trainings, statistics training, and advanced medical statistics training, delivered through the Altis E-School remote learning platform. Targeted at clinical research professionals and sponsor teams.
- AlfaBeta CRO Biostatistics Services Sister company and Turkey's first biostatistics firm, established in 2010, providing specialized biostatistics services integrated with ALTIS clinical trials, including statistical analysis planning, sample size calculations, randomization, and interim and final statistical analysis. Targeted at pharmaceutical and biotech sponsors.
Quantifiable outcome
- Reached and supported tens of thousands of patients over 20+ years
- +1 more outcomes
Companies that use ALTIS
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
ALTIS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
ALTIS partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AlfaBeta CROcoreAlfaBeta CRO is the sister company of ALTIS and Turkey's first biostatistics firm, established in 2010. The partnership provides integrated biostatistics services including statistical analysis planning, sample size calculations, randomization, and interim/final statistical analysis for clinical trials conducted by ALTIS.
Scale indicators5 records
Recent moves8 records
Expansion highlights4 records
ALTIS competitors and assessment
Company assessmentBroad incumbents
- PPD (Thermo Fisher Scientific): Major global CRO acquired by Thermo Fisher Scientific, offering comprehensive clinical development services. ALTIS's Country Operations Manager previously worked at Thermo Fisher/PPD, illustrating the talent pipeline between the two.
- ICON plc: Global CRO providing full-service clinical research, biometrics, and laboratory services. Competitor for international sponsor trials conducted in Turkey through regional partnerships.
- Medpace: Mid-to-large global CRO focused on full-service clinical development for sponsors. Operates in adjacent geographies and competes for mid-sized pharma trials that ALTIS also targets.
- Parexel International: Large global CRO with biopharmaceutical services spanning Phase I–IV trials, regulatory consulting, and biostatistics. Competes with ALTIS for multinational pharma trials in Turkey.
- IQVIA Turkey: Global CRO leader (formerly Quintiles) with established Turkey operations delivering Phase 1–4 trials, biostatistics, and real-world evidence. Competes with ALTIS for international pharma sponsors running trials in Turkey.
Direct peers
- Ergomed plc: Specialty CRO offering clinical research plus pharmacovigilance services, with strong oncology and rare disease focus. Comparable to ALTIS in being a full-service provider at sub-incumbent scale.
- Worldwide Clinical Trials: Mid-sized global CRO offering Phase 1–4 clinical trial management, biostatistics, and data management. Closely comparable to ALTIS in scale and full-service positioning, though with broader geographic reach.
- Monitor CRO Turkey: Turkey-based clinical research organization providing monitoring, site management, regulatory affairs, and data management services. Directly competes with ALTIS in the domestic Turkish CRO market.
- Omega CRO: Turkish CRO referenced in ALTIS management's employment history. Operates in the same clinical trial services space within Turkey, serving pharmaceutical and medical device sponsors with comparable Phase 1–4 capabilities.
Regional players
- SMO (Site Management Organization) Turkey: Turkish site management organizations and academic CROs that compete with ALTIS for site feasibility, patient recruitment, and investigator management in Turkey, though typically narrower in scope.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
ALTIS social profiles
Digital presenceALTIS compliance and trust
Trust signalCompliance4 records
ALTIS financial estimates
Financial estimateRevenue estimate
Valuation estimate
ALTIS leadership team
Management profileNumber of profiles
Profiles5 records
ALTIS subsidiaries and ownership
Company hierarchySubsidiaries1 record
ALTIS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ALTIS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ALTIS
What does ALTIS do?
ALTIS is a Contract Research Organization (CRO) that provides comprehensive clinical research services to pharmaceutical, biotechnology and medical device companies operating in Turkey. Its offerings cover Phase 1–4 clinical trials, observational and medical device studies, regulatory submissions to the Turkish Medicines and Medical Devices Agency (TMMDA), data management and biostatistics, medical software (protocols, CRF/eCRF), Interactive Voice/Web Response Systems (IXRS/IVRS/IWRS), training through Altis Academy, and supply of qualified clinical research personnel.
Is ALTIS a public or private company?
ALTIS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ALTIS founded?
ALTIS was founded in 2001. It employs 11 to 50 people.
Where is ALTIS based?
ALTIS is headquartered in Kadikoy.
How does ALTIS make money?
Three revenue lines are on record. Clinical Research Services are the primary driver. The others are qualified Clinical Research Personnel Supply and training Services.
Who are ALTIS's main competitors?
Broad incumbents on record are PPD (Thermo Fisher Scientific), ICON plc, Medpace, Parexel International and IQVIA Turkey. Direct peers are Ergomed plc, Worldwide Clinical Trials, Monitor CRO Turkey and Omega CRO. SMO (Site Management Organization) Turkey is listed as a regional player.
Does ALTIS have an API?
No public API is recorded for ALTIS.
What industry is ALTIS in?
ALTIS's product category is Contract Research Services (Clinical Research Organization). Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 54171 and its SIC code is 8731.